NCT06898268View on ClinicalTrials.gov

Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux

NACompletedINTERVENTIONAL

Enrollment

290

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Gastroesophageal Reflux Disorder

Interventions

DRUG

Metoclopramide

Patients were prescribed metoclopramide twice a day for one week.

DRUG

Ondansetron

Patients were put on oral ondansetron in BD doses for one week.

Trial Locations (1)

32200

Allama Iqbal Teaching Hospital, Dera Ghazi Khan

All Listed Sponsors

lead

Muhammad Aamir Latif

OTHER

NCT06898268 - Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux | Biotech Hunter | Biotech Hunter